BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the prestigious Precision Medicine World Conference (PMWC) in Silicon Valley.

The research, conducted by researchers at the University of Oregon and published in Current Biology, provides the first ...

Akribion Therapeutics (“Akribion”), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...